CPhI China hosted by UBM EMEA and CCCMHPIE and co-organised by UBM Sinoexpo will be returning to the Shanghai New International Exhibition Centre (SNIEC) China from June 21 to 23, 2016. The event is once again held in conjunction with P-MEC China and will co-locate with ICSE, BioPh, Innopack, LABWorld, NEX China, P-Logi, Clean Room & EP, Hi China, co-located with Fi Asia- China.
Pharma executives will meet, target prospect and conduct business, whilst obtaining the latest insight from across a market that is rapidly advancing up the value chain and tightening regulations, but simultaneously, lowering production costs.
CPhI & P-MEC China provide the perfect platform to harness this diverse market’s considerable opportunities, having evolved and grown alongside the industry for the last 16 years. At the 2016 event the floor space will expand to 150,000m2, accommodating over 2,800 exhibitors including over 1,130 pharma ingredients exhibitors, 400 plus biopharmaceutical and natural extracts specialists, 500 plus pharma machinery professionals and more than 150 pharmaceutical packaging, materials & drug delivery experts.
The eleven-in-one show brings together over 35,000 attendees from more than 120 countries, including Germany, USA, Italy, Japan, China, Russia, India, Korea, Hong Kong and other countries. The entire pharmaceutical supply chain will be present via 12 dedicated product zones: from APIs to outsourcing, CRO/CMO, packaging, biopharmaceuticals, natural extracts, machinery and more.
Beyond the exhibition floor, an extensive four-day programme will include over 182 speakers from China and international thought-leaders, presenting more than 50 seminars, 24 high level forums, and two C-level networking events across three days. The programme has been tailored in conjunction with Pharmaceutical Outsourcing and Pharmaceutical Technology magazines to create an agenda that demonstrates the essential tools to build trust and relationships in China, remove the perceived barriers, and feature trends in the current business and manufacturing environment.
New features of CPhI China 2016 are as follows.
Supplier Finder System – An interactive floor plan that utilises a dedicated screen so onsite visitors will be able to discover the location of existing or future suppliers, based on the search by a company name, product name or company’s stand number.
Matchmaking Programme – A dedicated platform to optimize the time at the show covering 150,000m2. This platform allows attendees to pre-arrange meetings with their selected exhibitors, according to their business goals.
CPhI TV will bring live interviews from the top companies on the show floor and live content onsite to get the best out of the show.
The Natural Extract Discover tours, guided by experts will direct people through the busy show floor and present them with key players in the Natural Extract Sector.
The Innovation Tours will provide attendees with the latest insight into functional and insulin packaging solutions in the Chinese market, as well as the opportunity to meet exhibitors across the show floor.
Says Andreas Mavrommatis, marketing director at UBM EMEA “China has been an increasingly dominant force in pharma for the last decade and already leads in total volumes of APIs and excipients. But we are now seeing an increasingly large number of providers across the full spectrum of the pharma value chain attend at CPhI China. In particular, biopharmaceuticals, finished product providers, natural extracts and CROs are rapidly expanding. At CPhI China we have the largest gathering of the key players and companies from across the industry all looking to maximise opportunities in this huge domestic healthcare economy. But just as crucially, the scope to export pharmaceutical products worldwide.”